Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax, Inc. - Common Stock (NQ:NVAX)

7.560 -0.180 (-2.33%)
Streaming Delayed Price Updated: 11:01 AM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
62 63 Next >
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
Via Benzinga
US Supports Delay On COVID Patent Waiver Extension Decision
Developing countries have been pushing for a patent waiver extension for COVID-19, which many developed countries argue could discourage pharma companies from responding rapidly to future global health... 
Via Benzinga
3 Supercharged Growth Stocks With 393% to 1,153% Upside in 2023, According to Wall Street
Select Wall Street analysts believe these fast-growing companies could skyrocket next year. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Why Shares of Novavax Are Down Tuesday
A disagreement over a contract sent the stock tumbling. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Friday
  On Friday, 72 companies hit new 52-week lows. 
Via Benzinga
What's Going On With Novavax Stock?
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday after the company announced the World Health Organization (WHO) issued an updated Emergency Use Listing for its Nuvaxovid vaccine as a... 
Via Benzinga
Is Novavax Stock a Buy Now?
There's probably not much good news coming for this biotech in the near future. 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
3 Potentially Explosive Stocks to Buy Before 2023
These stocks suffered in 2022. And they have reason to rebound. 
Via The Motley Fool
Novavax Stock: Buy, Sell, or Hold in 2023?
The shares are heading for almost a 90% loss this year. 
Via The Motley Fool
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. 
Via Benzinga
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Novavax (NVAX) Stock Falls 10% After Ending Agreement With Gavi
Yesterday, Novavax announced it has terminated a key agreement, sending shares of NVAX stock plunging in today's session. 
Via InvestorPlace
Jack Ma's Ant Group Slapped With $1B Fine, Carl Icahn's Huge Short Position In GameStop, Novavax Culls COVID-19 Vaccine Alliance With GAVI: Top Stories Tuesday, Nov. 22
Reuters 
Via Benzinga
Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines
Novavax Inc (NASDAQ: NVAX) delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of its COVID-19 vaccine to low- and middle-income... 
Via Benzinga
Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025
These beaten-down innovators have industry-changing potential. 
Via The Motley Fool
What Is Going on With Novavax (NVAX) Stock Today?
Novavax (NVAX) stock is on the move Friday after regulators in Canada approved the vaccine company's adult booster shot for Covid-19. 
Via InvestorPlace
Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults
Health Canada has granted expanded approval to Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (COVID-19 Vaccine as a homologous booster in adults aged 18 and older. 
Via Benzinga
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
Australian health authorities have recommended against a fifth COVID-19 vaccine shot despite average daily cases having been 47% higher last week than the week before, said Health Minister Mark Butler... 
Via Benzinga
2 Cheap Stocks to Buy Right Now
Both companies performed well during the worst of the pandemic, but things have changed since then. 
Via The Motley Fool
Here Are All 23 Stocks I've Bought During the 2022 Bear Market
A historically bad year for Wall Street is a gift for long-term investors with cash at the ready. 
Via The Motley Fool
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
Via Benzinga
Nasdaq Bear Market: 3 Phenomenal Bargains That Can Double Your Money by 2027
These amazing deals are ripe for the picking and poised to deliver triple-digit returns in five years. 
Via The Motley Fool
Novavax Posts Unexpected Q3 Loss, But Revenue Surpass Expectations
Novavax Inc (NASDAQ: NVAX) revised its FY22 sales forecast for the second time in three months amid waning demand for COVID-19 vaccines. 
Via Benzinga
The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter Earnings
Investors are looking for one key positive metric from Novavax's third-quarter earnings. 
Via Investor's Business Daily
Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses
Via Benzinga
Preview: Novavax's Earnings
Novavax (NASDAQ:NVAX) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Novavax will report... 
Via Benzinga
7 Nasdaq Stocks Smart Investors Shouldn’t Touch With a 10-Foot Pole
With macro forces changing the paradigm in the equities sector and the broader economy, it’s time to consider Nasdaq stocks to avoid. 
Via InvestorPlace
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
62 63 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.